Psychiatrists' treatment preferences for generalized anxiety disorder
ConclusionsTreatment preferences for GAD by psychiatrists in the 3 West Balkan countries were mostly in accordance with treatment guidelines and treatment preferences for patients and for psychiatrists as patients were mostly concordant. However, some psychiatrists were more likely to choose pharmacotherapy for patients and psychotherapy for themselves as patients. These findings have implications for education of psychiatrists and for efforts to improve treatment guidelines and mental health services. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - November 1, 2017 Category: Psychiatry Authors: Milan Latas, Goran Trajkovi ć, Dimitar Bonevski, Andromahi Naumovska, Dušanka Vučinić Latas, Zoran Bukumirić, Vladan Starčević Tags: RESEARCH ARTICLE Source Type: research

ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting
ConclusionWe have detected a possible interaction between ABCB1 and CYP2D6 in affecting response of psychotic patients to drug treatment, in a naturalistic setting. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - November 1, 2017 Category: Psychiatry Authors: Georgios Papazisis, Antonios Goulas, Alexios Sarrigiannidis, Stavroula Bargiota, Diomidis Antoniadis, Nikolaos Raikos, Emmanouela Basgiouraki, Vasileios P. Bozikas, Georgios Garyfallos Tags: RESEARCH ARTICLE Source Type: research

Higher serotonin transporter availability in early ‐onset obsessive–compulsive disorder patients undergoing escitalopram treatment: A [11C]DASB PET study
ConclusionsThese findings indicate that the earlier the age of onset of OCD, the less serotonergic pathology there is and that this difference remains even after long‐term serotonin reuptake inhibitor treatment. Clinically, it might suggest that nonserotonergic treatments would be a better option for EOCD patients. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - November 1, 2017 Category: Psychiatry Authors: Junhee Lee, Bo ‐Hyung Kim, Euitae Kim, Oliver D. Howes, Kang Ik Kevin Cho, Youngwoo Bryan Yoon, Jun Soo Kwon Tags: SHORT COMMUNICATION Source Type: research

Issue Information
No abstract is available for this article. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - November 1, 2017 Category: Psychiatry Tags: ISSUE INFORMATION Source Type: research

C ‐reactive protein levels and treatment resistance in schizophrenia—A Danish population‐based cohort study
ConclusionsC‐reactive protein, as a single inflammatory marker, appears insufficient to detect treatment‐resistant schizophrenia. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 26, 2017 Category: Psychiatry Authors: Henriette Thisted Horsdal, Theresa Wimberley, Michael Eriksen Benros, Christiane Gasse Tags: SHORT COMMUNICATION Source Type: research

Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met
ConclusionsThis study is the first to date examining the impact of AUDs/SUDs and COMT variants on FER in an epidemiologically representative sample of subjects with schizophrenia. Our findings do not suggest an additional impairment from comorbid AUDs/SUDs on FER among subjects with schizophrenia, whilst COMT Val158Met, though based on a limited sample, might have a role just among those without AUDs/SUDs. Based on our results, additional research is needed also exploring differential roles of various substances. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 15, 2017 Category: Psychiatry Authors: Giuseppe Carr à, Gabriella Nicolini, Annamaria Lax, Francesco Bartoli, Filippo Castellano, Alessia Chiorazzi, Giulia Gamba, Mattia Bava, Cristina Crocamo, Costanza Papagno Tags: RESEARCH ARTICLE Source Type: research

Effects of caffeinated alcoholic beverages with low alcohol and high caffeine content on cognitive and motor functions
ConclusionsCABs that contains a higher ratio of caffeine to alcohol did not counteract the motor function impairments induced by alcohol. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Authors: Wan ‐Ju Cheng, Chun‐Cheng Lin, Yawen Cheng, Ming‐Chyi Huang Tags: RESEARCH ARTICLE Source Type: research

Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta ‐analysis
ConclusionLeptin increases induced by APs are present across all diagnoses. More comprehensive research is needed to understand the relationship between AP use and leptin levels across multiple diagnoses. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Authors: Renee ‐Marie Ragguett, Margaret Hahn, Giovanni Messina, Sergio Chieffi, Marcellino Monda, Vincenzo De Luca Tags: RESEARCH ARTICLE Source Type: research

Italian prescribing patterns in obsessive –compulsive disorder
Abstract The aim of the present study was to investigate psychopharmacological prescribing patterns in a large sample (n = 1815) of patients suffering from obsessive–compulsive disorder (OCD) recruited in 4 Italian centers specialized in OCD, in comparison to available national and international guidelines. The centers were asked to complete a specific data sheet questionnaire on patients' therapeutic status. Statistical analyses were carried out by SPSS. The results showed that almost all patients referred to the centers of Milan, Pisa and Rome received psychotropic medications, whereas only 59.9% (313) did so in Turi...
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Authors: Donatella Marazziti, Umberto Albert, Bernardo Dell'Osso, Antonio Tundo, Francesco Cuniberti, Giuseppe Maina, Ilenia Moroni, Beatrice Benatti, Federico Mucci, Gabriele Massimetti, Armando Piccinni, Vlasios Brakoulias Tags: RESEARCH ARTICLE Source Type: research

Does early antipsychotic response predict long ‐term treatment outcome?
ConclusionThese results demonstrate the long‐term prognostic value of early haloperidol response. The predictive value of early olanzapine response may be less robust. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Authors: Sean A. Rasmussen, Patricia I. Rosebush, Michael F. Mazurek Tags: RESEARCH ARTICLE Source Type: research

Human neutrophils show decreased survival upon long ‐term exposure to clozapine
ConclusionsThe effect of long‐term exposure to clozapine on neutrophil survival is plausibly associated with delayed onset of agranulocytosis after initial exposure. Our results suggest that human neutrophils are vulnerable to clozapine and its reactive metabolite in a concentration‐ and time‐dependent manner. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Authors: Aya Goto, Akira Yoshimi, Tomoko Nagai, Mako Ukigai, Akihiro Mouri, Norio Ozaki, Yukihiro Noda Tags: RESEARCH ARTICLE Source Type: research

Issue Information
No abstract is available for this article. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - September 1, 2017 Category: Psychiatry Tags: ISSUE INFORMATION Source Type: research

Multiple DSM ‐5 substance use disorders: A national study of US adults
ConclusionsAssessment, diagnosis, and treatment often focus on individual substance‐specific SUDs rather than multiple SUDs, despite evidence for substantial rates of polysubstance use in clinical and epidemiological studies. There are notable differences in the prevalence of multiple SUDs between alcohol use disorders and other nonalcohol SUDs that have important clinical implications; for example, multiple SUDs are more persistent than individual SUDs. These findings suggest that clinical assessment and diagnosis should screen for multiple SUDs, especially among adults with nonalcohol DSM‐5 SUDs. (Source: Human Psych...
Source: Human Psychopharmacology: Clinical and Experimental - July 27, 2017 Category: Psychiatry Authors: Sean Esteban McCabe, Brady T. West, Emily M. Jutkiewicz, Carol J. Boyd Tags: RESEARCH ARTICLE Source Type: research

Issue Information
No abstract is available for this article. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - July 19, 2017 Category: Psychiatry Tags: ISSUE INFORMATION Source Type: research

Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review
ConclusionsThe presence of coexisting anxiety symptoms and co‐morbid anxiety disorders should be ascertained when assessing patients with schizophrenia or other psychoses as a range of pharmacological and psychosocial treatments are available. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - July 1, 2017 Category: Psychiatry Authors: Fleur M. Howells, David G. Kingdon, David S. Baldwin Tags: REVIEW ARTICLE Source Type: research